Filing Details
- Accession Number:
- 0001140361-24-036617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-09 16:05:22
- Reporting Period:
- 2024-08-07
- Accepted Time:
- 2024-08-09 16:05:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1214938 | F Kevin Mclaughlin | C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-07 | 5,000 | $3.74 | 16,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-08-07 | 5,000 | $45.92 | 11,900 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-08-07 | 2,000 | $3.74 | 13,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-08-07 | 2,000 | $45.99 | 11,900 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-08-07 | 5,000 | $0.00 | 5,000 | $3.74 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-08-07 | 2,000 | $0.00 | 2,000 | $3.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | A | Direct | ||
| 13,000 | No | 4 | A | Direct |
Footnotes
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
- These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.
- These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.
- These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.
Billionaire Hedge Funds
